Stem cells: Cell therapy for cardiac repair: what is needed to move forward?

Changes in Circulating Biomarkers in Patients With Ischemic Heart Failure After Treatment With Autologous Mesenchymal Stromal Cells and c-Kit-Positive Cardiac Cells, Alone or in Combination: Results From the Cardiovascular Cell Therapy Research Network CONCERT-HF Clinical Trial.

Journal of the American Heart Association·2026

Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy.

American heart journal·2025

Spatial Distributions of Blood Residence Time in Stenosed Model Coronary Arteries.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025

Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial.

Transfusion·2025

Comparative Effects of Repeated Intravenous Infusions of Progenitor Cells in a Rat Model of Chronic Ischemic Cardiomyopathy.

Stem cell reviews and reports·2025